Cormorant Asset Management, LP Merus N.V. Transaction History
Cormorant Asset Management, LP
- $1.27 Billion
- Q4 2024
A detailed history of Cormorant Asset Management, LP transactions in Merus N.V. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 740,000 shares of MRUS stock, worth $31.4 Million. This represents 2.46% of its overall portfolio holdings.
Number of Shares
740,000
Previous 740,000
-0.0%
Holding current value
$31.4 Million
Previous $37 Million
15.83%
% of portfolio
2.46%
Previous 2.59%
Shares
11 transactions
Others Institutions Holding MRUS
# of Institutions
203Shares Held
57.2MCall Options Held
111KPut Options Held
85.7K-
Rtw Investments, LP New York, NY4.17MShares$177 Million2.86% of portfolio
-
Commodore Capital LP New York, NY3.87MShares$164 Million16.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.97MShares$126 Million3.1% of portfolio
-
Samlyn Capital, LLC New York, NY2.67MShares$113 Million1.81% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.13MShares$90.2 Million1.3% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.95B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...